Prevalence of Gastroesophageal Reflux Disease in Primary Care Patients With Upper Gastrointestinal Symptoms

AstraZeneca

Status: Completed

Conditions: Gastroesophageal Reflux Disease

Study type: Observational

Funder types: Industry

Identifiers

NCT01020890

NIS-GBG-NEX-2009/1

Details and patient eligibility

About

The purpose of this study is to provide data on the gastroesophageal reflux disease (GERD) prevalence as percentage of patients with upper gastrointestinal (GI) symptoms that are identified with GERD using the Gerd-Q Questionnaire.

Enrollment: 2,210 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients with upper gastrointestinal symptoms

Exclusion criteria

• History of oesophageal, gastric or duodenal surgery
• Current treatment with antiinflammatory drugs, including OTC
• Current treatment with proton pump inhibitors ang H2-blockers